David J Hunter
David J Hunter
Case 10-2025: A 32-Year-Old Woman with Flank Pain, Fever, and Hypoxemia [0.03%]
病例报告10-2025：一名32岁女性患者的腰痛、发热和低氧血症
Anushya Jeyabalan,Cynthia L Czawlytko,Laurence H Beck Jr et al.
Anushya Jeyabalan et al.
Pemphigus Foliaceus [0.03%]
落叶性天疱疮
Bladimir Rodriguez-Lechtig,Adriana Motta
Bladimir Rodriguez-Lechtig
Otitis Media in Young Children [0.03%]
幼儿中耳炎
Nader Shaikh
Nader Shaikh
Jana K McHugh,Elizabeth K Bancroft,Edward Saunders et al.
Jana K McHugh et al.
Background: The incidence of prostate cancer is increasing. Screening with an assay of prostate-specific antigen (PSA) has a high rate for false positive results. Genomewide association studies have identified common germ...
Thomas M Maddox,Peter Embí,Jackie Gerhart et al.
Thomas M Maddox et al.
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis [0.03%]
托利布替尼治疗非进展性 secondary progressive 多发性硬化症
Robert J Fox,Amit Bar-Or,Anthony Traboulsee et al.
Robert J Fox et al.
Background: Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple sclerosis have lim...
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis [0.03%]
托莱布利丁与特里氟诺米治疗复发性多发性硬化症的对比研究
Jiwon Oh,Douglas L Arnold,Bruce A C Cree et al.
Jiwon Oh et al.
Background: Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton's tyrosine kinase inhibitor that modulates peripheral inflammation and persistent immune activation within the central nervous system, including d...
Richard J Nowak,Michael Benatar,Emma Ciafaloni et al.
Richard J Nowak et al.
Background: Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to disease pathogenes...
Debra F Weinstein,Elena Olson,John Patrick T Co
Debra F Weinstein